Diverse perspectives on science and medicine
Plan S, the open access strategy from European funders in cOAlition S, gained momentum in 2019. However it pushed back its start date in May (to 2021), aiming for 2024 as the year
This is the sixth year I’ve rounded up the year in open access – and it was the most remarkable. When the year began, the world’s largest academic publisher, Elsevier, had increased their
This was the fifth year I tracked events in open access. Sifting through the mass of developments I collected along the way, a couple stood out. The first is the showdown going on
A few years ago, I wrote that open access (OA) publications were gaining momentum. Based on a study of 2006 to 2010 in the biomedical literature database, PubMed, our access to publications was apparently growing
It’s the year many negotiators got seriously tough on double dipping – charging for both the ability to read (via subscriptions) and for publishing (author processing charges, or APCs). Last year it was France getting tough
Scientists created a rod for their backs when they allowed the journals in which their work is published to become the arbiters of its scientific merit. A small tier of journals locked behind expensive
Was this the year open access for science reached critical mass? One hypothesis suggests that a transformative group needs to reach one-third to be prominent and persisting. Rogers’ theory on the diffusion of innovations that